InvestorsHub Logo
Followers 800
Posts 50882
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Friday, 06/21/2019 9:08:27 AM

Friday, June 21, 2019 9:08:27 AM

Post# of 255
Axovant Gene Therapies started at outperform with $18 stock price target at SVB Leerink
8:07 am ET June 21, 2019 (MarketWatch)
Share
Print
(END) Dow Jones Newswires

June 21, 2019 08:07 ET (12:07 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

New York Yankees and Duke Basketball

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.